MustGrow Biologics Corp.
MGROF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.02 | 1.08 | -0.54 | 2.61 |
| FCF Yield | -5.22% | -0.46% | -1.91% | -1.44% |
| EV / EBITDA | -109.96 | -124.49 | -540.48 | -562.57 |
| Quality | ||||
| ROIC | -175.55% | -12.69% | -94.78% | -32.71% |
| Gross Margin | 75.56% | 91.85% | -4,506.87% | -1,484.19% |
| Cash Conversion Ratio | 0.73 | 0.44 | 0.59 | 0.79 |
| Growth | ||||
| Revenue 3-Year CAGR | 294.58% | 615.41% | – | – |
| Free Cash Flow Growth | -1,113.95% | 90.95% | -35.07% | 6.48% |
| Safety | ||||
| Net Debt / EBITDA | 4.13 | 13.00 | 20.58 | 31.46 |
| Interest Coverage | 0.00 | 0.00 | -564.77 | -57.06 |
| Efficiency | ||||
| Inventory Turnover | 0.07 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -2,999.61 | -230.34 | -231.42 | -407.26 |